Standards of Medical Care in Diabetes MASLD and Type 2 Diabetes – Integration of Hepatic and Metabolic Dysfunction Management Guidelines (2025) American Diabetes Association (ADA)

Description

A comprehensive guideline detailing the 2025 American Diabetes Association standards concerning the diagnosis, screening, and therapeutic management of patients presenting with both Type 2 Diabetes Mellitus (DM2) and Metabolic dysfunction-associated Steatotic Liver Disease (MASLD). This edition focuses on the current evidence base for lifestyle, pharmacological interventions, and monitoring protocols for complex cardio-metabolic risk factors.